Tom W. Roques
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
Papers in
-
- Head and Neck Cancer Studies 17
-
- Cancer Genomics and Diagnostics 16
- Co-authors
- Ann Barrett (2 shared papers)Richard David Smith (1 shared paper)Matthew Small (1 shared paper)S. C.ONWAY MORRIS (2 shared papers)Suat Wei Loo (8 shared papers)Katie L. Spencer (3 shared papers)Konstantinos Geropantas (5 shared papers)Michael Sharpe (1 shared paper)
- Journals
- Nature Communications (11 papers)Clinical Oncology (10 papers)The Lancet Oncology (9 papers)Nature (6 papers)Nature Genetics (6 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Tom W. Roques
84 papers receiving 12.8k citations
Tom W. Roques's Hit Papers
Peers
Comparison fields: 5 of 163
- Cancer Research 4.3k
- Otorhinolaryngology 952
- Oncology 3.0k
- Molecular Biology 5.3k
- Pathology and Forensic Medicine 1.1k
Countries citing papers authored by Tom W. Roques
This map shows the geographic impact of Tom W. Roques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom W. Roques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom W. Roques more than expected).
Fields of papers citing papers by Tom W. Roques
This network shows the impact of papers produced by Tom W. Roques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom W. Roques. The network helps show where Tom W. Roques may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom W. Roques, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 2 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 3 | Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial Hit paper breakdown → | 2018 | 767 |
| 4 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 5 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 6 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 7 | Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer Hit paper breakdown → | 2012 | 469 |
| 8 | COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Hit paper breakdown → | 2020 | 443 |
| 9 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 419 |
| 10 | Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial Hit paper breakdown → | 2014 | 327 |
| 11 | 2020 | 317 | |
| 12 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 309 |
| 13 | 2020 | 301 | |
| 14 | 2020 | 293 | |
| 15 | 2015 | 233 | |
| 16 | 2020 | 184 | |
| 17 | 2020 | 160 | |
| 18 | 2020 | 159 | |
| 19 | 2020 | 152 | |
| 20 | Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2024 | 133 |
About Tom W. Roques
Tom W. Roques is a scholar working on Otorhinolaryngology, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 89 papers that have together received 13.0k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (17 papers), Cancer Genomics and Diagnostics (16 papers), Genetic factors in colorectal cancer (8 papers), Advances in Oncology and Radiotherapy (8 papers), COVID-19 and healthcare impacts (6 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Genomics and Chromatin Dynamics (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (4.3k citations), Otorhinolaryngology (952 citations), Oncology (3.0k citations), Molecular Biology (5.3k citations) and Pathology and Forensic Medicine (1.1k citations). Tom W. Roques has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Ann Barrett, Richard David Smith, Matthew Small, S. C.ONWAY MORRIS, Suat Wei Loo, Katie L. Spencer, Konstantinos Geropantas, Michael Sharpe, Christopher Mark Jones and Mererid Evans. Their work appears in journals such as Nature Communications, Clinical Oncology, The Lancet Oncology, Nature and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.